Rilpivirine-structure (8d833cc1 60b6 4e31 Aff3 2958b8f93d1f 01)
Rilpivirine Tablet, Film Coated
Product Images NDC 70069-848
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rilpivirine (NDC 70069-848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Desc (8d833cc1 60b6 4e31 Aff3 2958b8f93d1f 02)
This text contains information about Rilpivirine tablets manufactured by Somerset Therapeutics, LLC. Each tablet contains 27.5 mg of rilpivirine hydrochloride, equivalent to 25 mg. It provides guidelines for storage at a temperature between 20° to 25°C. The text indicates that Rilpivirine tablets should be stored in the original bottle to protect them and kept out of reach of children. It also mentions that Rilpivirine tablets are not a substitute for Edurant. Users are advised to consult their healthcare provider for information on medications that should not be taken with Rilpivirine tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
